C4 Therapeutics shares owned by TD Asset Management
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by TD Asset Management
from 13F filings
Historical chart of TD Asset Management investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in C4 Therapeutics by TD Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $256k | 43k | 5.89 |
2024-03-31 | $758k | 93k | 8.17 |
2023-12-31 | $533k | 94k | 5.65 |
2023-06-30 | $133k | 49k | 2.75 |
2023-03-31 | $152k | 49k | 3.14 |
2022-12-31 | $286k | 49k | 5.90 |
2022-09-30 | $414k | 49k | 8.54 |
2022-06-30 | $416k | 55k | 7.54 |
2022-03-31 | $2.6M | 107k | 24.26 |
2021-12-31 | $3.4M | 106k | 32.20 |
2021-09-30 | $4.5M | 100k | 44.68 |
2021-06-30 | $4.1M | 96k | 43.14 |
2021-03-31 | $2.5M | 67k | 36.99 |
2020-12-31 | $523k | 16k | 33.14 |